Transfusion of Ipscs-Derived Leukocytes to Kill Cancer - Journal of Cancer Therapy

JCT > Vol.1 No.1, March 2010

Transfusion of Ipscs-Derived Leukocytes to Kill Cancer ()

HTML XML

Download as PDF (Size: 150KB) PP. 29-30

DOI: 10.4236/jct.2010.11004 5,006 Downloads 8,609 Views Citations

Author(s)

Jiang Li, Ying Cui, Guodong Gao, Ti-Fei Yuan

Affiliation(s)

.
Department of Clinical Laboratory and Research center of Tang Du Hospital, The Forth Military Medical University; Xi’an, China.
Department of Neurosurgery, Tang Du Hospital, The Fourth Military University, Xi’an, China.

ABSTRACT

Here we propose that the rejuvenation of leukocytes with iPSC technology in vitro and transfusion of cancer cellresistant white blood cells back to human body provide a prospective therapy for cancer patients.

KEYWORDS

Ipscs, Leukocytes, Cancer

Share and Cite:

J. Li, Y. Cui, G. Gao and T. Yuan, "Transfusion of Ipscs-Derived Leukocytes to Kill Cancer," Journal of Cancer Therapy, Vol. 1 No. 1, 2010, pp. 29-30. doi: 10.4236/jct.2010.11004.

Journals Menu